Pharmacological management of atrial fibrillation following cardiac surgery

American Journal of Cardiovascular Drugs

Volumn 5, Issue 6, 2005, Pages 361-369

  Hilleman, Daniel E ^a   Hunter, Claire B ^a   Mohiuddin, Syed M ^a   Maciejewski, Stephanie ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; MAGNESIUM; METOPROLOL; PLACEBO; PROCAINAMIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

AGE DISTRIBUTION; ANAMNESIS; AORTA BALLOON; ARTIFICIAL VENTILATION; BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DRUG INDICATION; DRUG MECHANISM; FORWARD HEART FAILURE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART PROARRHYTHMIA; HEART RATE; HEART SURGERY; HEMODYNAMICS; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; LENGTH OF STAY; META ANALYSIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY BYPASS; ELECTRIC COUNTERSHOCK; HUMANS; INCIDENCE; LENGTH OF STAY; META-ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS;

EID: 27744481382     PISSN: 11753277     EISSN: 11753277     Source Type: Journal    
DOI: 10.2165/00129784-200505060-00003     Document Type: Review

References (73)

1. American Heart Association. Heart and stroke statistical update. Dallas (TX): American Heart Association, 2004
2. Weintraub WS, Becker ER, Mauldin PD, et al. Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). Am J Cardiol 2000; 86: 747-52
3. Doering LV, Esmailian F, Laks H. Perioperative predictors of ICU and hospital costs in coronary artery bypass graft surgery. Chest 2000; 118: 736-43
4. Fuller JA, Adams GC, Buxton B. Atrial fibrillation after coronary artery bypass grafting: is it a disorder of the elderly? J Thorac Cardiovas Surg 1989; 97: 821-5
5. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996; 94: 390-7
6. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary bypass artery graft surgery: predictors, outcomes, and resource utilization. JAMA 1996; 276: 300-6
7. Frost L, Molgaard H, Christiansen EH, et al. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors, and preventive trials. Int J Cardiol 1992; 36: 253-61
8. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of post-operative atrial arrhythmias. Ann Thorac Surg 1993; 56: 539-49
9. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. Circulation 1991; 84 Suppl. III: 236-43
10. Kowey PR, Taylor JE, Rials SJ, et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69: 963-5
11. Lauer MS, Eagle KA, Buckley MJ, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367-78
12. Rubin DA, Nieminski KE, Reed GE, et al. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987; 94: 331-5
13. Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J 2000; 140: 871-7
14. Leitch JW, Thomson D, Baird DK, et al. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100: 338-42
15. Crosby LH, Pifalo WB, Woll KR, et al. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990; 66: 1520-2
16. White HD, Antman GM, Glynn MA, et al. Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation 1984; 70: 479-84
17. Salazar C, Frishman WH, Friedman S, et al. Beta-blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome? Angiology 1979; 30: 816-9
18. Olshansky B. Management of atrial fibrillation after coronary artery bypass graft surgery. Am J Cardiol 1996; 78: 27-34
19. Singh BN, Lopez B, Sarma JSM. Significance and prevention of atrial fibrillation occurring after cardiac surgery: a time for fundamental change in strategy? J Cardiovasc Pharmacol Ther 1998; 3: 259-68
20. Taylor GJ, Malik SA, Colliver JA, et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol 1987; 60: 905-7
21. Stamou SC, Hill PC, Dangas G, et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001; 32: 1508-13
22. Lahtinen J, Biancari F, Salmela E, et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 1241-4
23. Stamou SC, Jablonski KA, Pfister AJ, et al. Stoke after conventional versus minimally invasive coronary artery bypass. Ann Thorac Surg 2002; 74: 394-9
24. Reed GL, Singer DE, Picard EH, et al. Stroke following coronary-artery bypass surgery: a case-control estimate of the risk from carotid bruits. N Engl J Med 1988; 319: 246-50
25. Kapetanakis EI, Stamou SC, Dullum MK, et al. The impact of aortic manipulation on neurologic outcomes after coronary artery bypass surgery: a risk adjusted study. Ann Thorac Surg 2005; 78: 1564-71
26. Davison R, Hertz R, Kaplan K, et al. Prophylaxis of supraventricular tachyarrhythmias after coronary artery bypass surgery with oral verapamil: a randomized, double-blinded trial. Ann Thorac Surg 1985; 39: 336-9
27. Hravnak M, Hoffman LA, Saul MI, et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am J Crit Care 2002 May; 11 (3): 228-38
28. Crystal E, Connolly SJ, Sleik K, et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002; 106: 75-80
29. Hohnloser SH, Meinertz J, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991; 121: 89-95
30. Butler J, Harriss DR, Sinclair M, et al. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomized, double-blind, placebo controlled trial. Br Heart J 1993; 70: 56-60
31. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337: 1785-91
32. Redle JD, Khurana S, Marzan R, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999; 138: 144-50
33. Guarneri T, Nolan S, Gottlieb SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) Trial. J Am Coll Cardiol 1999; 34: 343-7
34. Doerge HC, Schoendube FA, Vogt M, et al. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with intravenous amiodarone. Circulation 1996; 94 Suppl. I: 1-190
35. Treggiari-Venzi MM, Waeber JL, Perneger TV, et al. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anesth 2000; 85: 690-5
36. Lee S, Chang C, Lu M, et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary after bypass grafting. Ann Thorac Surg 2000; 70: 157-61
37. Harahsheh BS, Sawalha WA. Effect of amiodarone on atrial fibrillation after coronary artery bypass surgery. Saudi Med J 2001; 22: 797-9
38. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 2001; 357: 830-6
39. Maras D, Boskovic SD, Popovic Z, et al. Single day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am Heart J 2001; 141: e8
40. White CM, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003; 108 Suppl. II: 200-6
41. Auer J, Weber T, Berent R, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot Study of Prevention of Postoperative Atrial Fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 2004; 147: 636-43
42. Mooss AN, Wurdeman RL, Sugimoto JT, et al. Amiodarone versus sotalol for the treatment atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004; 148: 641-8
43. Janssen J, Loomans L, Harink J, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology 1986; 37: 601-9
44. Suttorp MJ, Kingma JH, Peels HO, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol 1991; 68: 1163-9
45. Nystrom U, Edvardsson N, Berggren H, et al. Oral sotalol reduces the incidence of atrial fibrillation artery coronary artery bypass surgery. Thorac Cardiovasc Surg 1993; 41: 34-7
46. Jacquet L, Verhelst R, Dion R, et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1994; 8: 431-6
47. Pfisterer ME, Kloter-Weber UC, Huber M, et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. Ann Thorac Surg 1997; 64: 1113-9
48. Kloter-Weber UC, Osswald S, Buser P, et al. Significance of supraventricular tachyarrhythmias after coronary artery bypass graft surgery and their prevention by low-dose sotalol: a prospective double-blind randomized placebo-controlled study. J Cardiovasc Pharmacol Ther 1998; 3: 209-11
49. Evrard P, Gonzalez M, Jamart J, et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting. Ann Thorac Surg 2000; 70: 151-6
50. Gomes JA, Ip J, Santoni-Rugin F, et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34: 334-9
51. Forlani S, De Paulis R, de Notaris S, et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary after coronary artery bypass grafting. Ann Thorac Surg 2002; 74: 720-6
52. Abdulrahman O, Dale HT, Levin V, et al. Low dose sotalol is superior to metoprolol in the prevention of supraventricular arrhythmias after cardiac surgery. J Am Coll Cardiol 1999; 33 Suppl. 2: 132A-3A
53. Parikka H, Toivonen L, Heikkila L, et al. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol 1998; 31: 67-73
54. Suttorp MJ, Kingma JH, Tjon Joe Gin RM, et al. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg 1990; 100: 921-6
55. Fazekas T, Scherlag BJ, Vos M, et al. Magnesium and the heart: antiarrhythmic therapy with magnesium. Clin Cardiol 1993; 16: 768-74
56. 2+ transport in the heart. Nature 1990; 346: 841-4
57. Zaman AG, Alamgir F, Richens T, et al. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 1977; 77: 527-31
58. England MR, Gordon G, Salem M, et al. Magnesium administration and dysrhythmias after cardiac surgery: a placebo-controlled, double-blind, randomized trial. JAMA 1992; 268: 2395-402
59. Fanning WJ, Thomas CS, Roach A, et al. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 1991; 52: 529-33
60. Shiga T, Wajima Z, Inoue T, et al. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med 2004; 117: 325-33
61. Toraman F, Karabulut H, Alhan C, et al. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 1256-62
62. Parrika H, Toivonen L, Pellinen T, et al. The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J 1993; 14: 251-8
63. Geertman H, van der Starre PJ, Sie HT, et al. Magnesium in addition to sotalol does not influence the incidence of postoperative atrial tachyarrhythmias after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2004; 18: 309-12
64. Hazelrigg SR, Boley TM, Cetindag IB, et al. The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2004; 77: 824-30
65. Soucier R, Silverman D, Abordo M, et al. Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compare to rate control alone (the PIPAF study). Med Sci Monit 2003; 9: 19-23
66. Bernard EO, Schmid ER, Schmidlin D, et al. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Crit Care Med 2003; 31: 1031-4
67. Bechtel JF, Christianson JF, Sievers HH, et al. Low-energy cardioversion versus medical treatment for the termination of atrial fibrillation after CABG. Ann Thorac Surg 2003; 75: 1185-8
68. Gerstenfeld EP, Khoo M, Martin RC, et al. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol 2001; 5: 275-83
69. Blitzer M, Costeas C, Kassosits J, et al. Rhythm management in atrial fibrillation-with a primary emphasis on pharmacological therapy: part 1. PACE 1998; 21: 590-602
70. Tisdale JE, Padhi ID, Goldberg AD, et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998; 135: 739-47
71. Balser JR, Martinez ZA, Winters BD, et al. Beta-adrenergic blockade accelerates conversion of post-operative supraventricular tachyarrhythmias. Anesthesiology 1998; 89: 1052-9
72. Mooss AN, Wurdeman RL, Mohiuddin SM, et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after cardiac surgery. Am Heart J 2000; 140: 176-80
73. Hilleman DE, Reyes AP, Mooss AN, et al. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin 2003; 19: 376-82